gabexate has been researched along with Emergencies in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Emergencies: Situations or conditions requiring immediate intervention to avoid serious adverse results.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yawata, Y | 1 |
| Mikata, N | 1 |
| Imao, S | 1 |
| Tanaka, Y | 1 |
| Horiuchi, D | 1 |
| Matsumoto, G | 1 |
| Hasegawa, K | 1 |
1 review available for gabexate and Emergencies
| Article | Year |
|---|---|
[Emergency therapy of disseminated intravascular coagulation].
Topics: Anticoagulants; Blood Coagulation; Disseminated Intravascular Coagulation; Emergencies; Gabexate; He | 1995 |
1 other study available for gabexate and Emergencies
| Article | Year |
|---|---|
[A case of renal cancer complicated with acute hypercalcemia and acute pancreatitis].
Topics: Acute Disease; Calcitonin; Emergencies; Gabexate; Guanidines; Humans; Hypercalcemia; Kidney Neoplasm | 1989 |